J Škrha

6.1k total citations · 1 hit paper
151 papers, 4.0k citations indexed

About

J Škrha is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, J Škrha has authored 151 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Surgery and 30 papers in Molecular Biology. Recurrent topics in J Škrha's work include Diabetes Treatment and Management (21 papers), Advanced Glycation End Products research (20 papers) and Diabetes Management and Research (18 papers). J Škrha is often cited by papers focused on Diabetes Treatment and Management (21 papers), Advanced Glycation End Products research (20 papers) and Diabetes Management and Research (18 papers). J Škrha collaborates with scholars based in Czechia, United States and Russia. J Škrha's co-authors include Marta Kalousová, Tomáš Zima, Martin Prázný, G Šindelka, Michael H. Shanik, Yuping Xu, Yehiel Zick, Rachel Dankner, Jesse Roth and Jan Šoupal and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

J Škrha

146 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Insulin Resistance and Hyperinsulinemia

2008 589 citations J Škrha et al. profile →

Peers

Countries citing papers authored by J Škrha

Since Specialization

Citations

This map shows the geographic impact of J Škrha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Škrha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Škrha more than expected).

Fields of papers citing papers by J Škrha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Škrha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Škrha. The network helps show where J Škrha may publish in the future.

Co-authorship network of co-authors of J Škrha

This figure shows the co-authorship network connecting the top 25 collaborators of J Škrha. A scholar is included among the top collaborators of J Škrha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Škrha. J Škrha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-lowering Agents: Challenges of inpatient diabetes care identified by EFIM’s Diabesity Day Survey 2024 2025 ·European Journal of Internal Medicine ·(unknown), (unknown), (unknown), Dimitrios Patoulias, Dirk Müller‐Wieland, Dror Dicker, (unknown), (unknown), J Škrha, Julia Brandts, Ricardo Gómez‐Huelgas, (unknown), (unknown), Theocharis Koufakis, Yusuf Ziya Şener, (unknown), Alexandra Kautzky‐Willer	1
2	The Effect of Nutrition Education on Glycemic Outcomes in People With Type 1 Diabetes Initiating the Use of Glucose Sensors 2025 ·Endocrinology Diabetes & Metabolism ·(unknown), (unknown), Jan Šoupal, J Škrha, (unknown), (unknown), Aneta Hašková, Martin Prázný, Eva Horová	1
3	Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus 2022 ·Journal of Diabetes and its Complications ·J Škrha, (unknown), Eva Horová, Jan Šoupal, Anna Valeriánová, Jan Malík, Martin Prázný, Tomáš Zima, Marta Kalousová, (unknown)	4
4	Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus 2017 ·Central European Journal of Public Health ·Ivan Raška, (unknown), Vı́t Zikán, J Škrha	29
5	High Prevalence of Hypovitaminosis D in Postmenopausal Women with Type 2 Diabetes Mellitus 2016 ·Prague Medical Report ·Ivan Raška, (unknown), Vı́t Zikán, J Škrha	11
6	Glucose variability, HbA1c and microvascular complications 2016 ·Reviews in Endocrine and Metabolic Disorders ·J Škrha, Jan Šoupal, Martin Prázný	111
7	[Glycation of lens proteins in diabetes and its non-invasive assessment - first experience in the Czech Republic]. 2015 ·PubMed ·J Škrha, Jan Šoupal, Martin Prázný, (unknown)	2
8	Glycemic Variability Is Higher in Type 1 Diabetes Patients with Microvascular Complications Irrespective of Glycemic Control 2014 ·Diabetes Technology & Therapeutics ·Jan Šoupal, J Škrha, (unknown), Eva Horová, Miloš Mráz, Martin Prázný	97
9	Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus 2013 ·Journal of Diabetes Research ·J Škrha, (unknown), Jan Šoupal, (unknown), Martin Prázný, Marta Kalousová, J Kvasnička, (unknown), Tomáš Zima, (unknown), (unknown)	15
10	Pheochromocytoma and Markers of Oxidative Stress 2013 ·Physiological Research ·(unknown), Ondřej Petrák, J Škrha, J Widimský, Tomáš Zelinka	8
11	Levels of Circulating Biomarkers at Rest and after Exercisein Coronary Artery Disease Patients 2010 ·Physiological Research ·Vilém Danzig, (unknown), Petr Kuchynka, Hana Benaková, Tomáš Zima, Otomar Kittnar, J Škrha, Aleš Linhart, Marta Kalousová	40
12	Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus 2008 ·BMC Medical Genetics ·Milan Flekač, J Škrha, J Hilgertová, Z Lacinová, (unknown)	131
13	Influence of PPAR-alpha agonist fenofibrate on insulin sensitivity and selected adipose tissue-derived hormones in obese women with type 2 diabetes 2007 ·Physiological Research ·Kateřina Anderlová, (unknown), J Housová, Lenka Bošanská, D Haluzíková, (unknown), J Škrha, Martin Haluzı́k	37
14	Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control 2005 ·Physiological Research ·Martin Prázný, J Škrha, Z Límanová, Zdislava Vaníčková, J Hilgertová, (unknown), (unknown), Ilja Střı́ž	28
15	Microvascular reactivity in patients with hypercholesterolemia: the effect of lipid lowering treatment 2003 ·Physiological Research ·Tomáš Štulc, (unknown), Martin Prázný, Michal Vráblík, J Škrha, R Češka	23
16	Does the treatment of primary hyperaldosteronism influence glucose tolerance? 2003 ·Physiological Research ·Branislav Štrauch, J Widimský, G Šindelka, J Škrha	32
17	The relationship between the system of IGF-I and its binding proteins and microvascular reactivity in type 1 diabetes mellitus 2002 ·Physiological Research ·Michal Kršek, Martin Prázný, J Škrha, V Justová, Z Lacinová, T Haas	5
18	Relationship of serum N-acetyl-β-glucosaminidase activity to oxidative stress in diabetes mellitus 1999 ·Clinica Chimica Acta ·J Škrha, J Hilgertová	16
19	[The effect of insulin in primary hyperaldosteronism]. 1998 ·PubMed ·G Šindelka, J Widimský, Martin Prázný, J Hilgertová, J Škrha	1
20	The Effect of Fasting and Vitamin E on Insulin Action in Obese Type 2 Diabetes Mellitus 1997 ·Annals of the New York Academy of Sciences ·J Škrha, G Šindelka, J Hilgertová	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact